FDA authorizes bivalent booster for people 5 and up

More
The updated booster shots were initially authorized for people 12 years of age and older.
0:46 | 10/12/22

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Resume Playing Video
Comments
Related Extras
Related Videos
Video Transcript
Transcript for FDA authorizes bivalent booster for people 5 and up
[MUSIC PLAYING] REPORTER: The FDA announced its authorization Wednesday for bivalent COVID-19 boosters for young children. The Pfizer shot has been authorized for kids five and up, while the Moderna has been authorized for six and up. The bivalent boosters were initially only authorized for use by people 12 and older in late August. The FDA says children can receive the booster at least two months after completing their primary series. The updated boosters specifically target the BA.4 and BA.5 Omicron sub variants of COVID-19. As of October 6, only 11.5 million Americans had received the updated bivalent booster shot since September 1st. [MUSIC PLAYING]

This transcript has been automatically generated and may not be 100% accurate.

  • Now Playing: {{itm.title}}

{"duration":"0:46","description":"The updated booster shots were initially authorized for people 12 years of age and older. ","mediaType":"default","section":"ABCNews/Health","id":"91391051","title":"FDA authorizes bivalent booster for people 5 and up ","url":"/Health/video/fda-authorizes-bivalent-booster-people-91391051"}